General Information of the Compound
| Compound ID |
CP0255165
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-(1,3-thiazol-2-yl)thieno[3,2-d]pyrimidin-2-amine
Show/Hide
|
||||||||||||||||||
| Synonyms |
4-(2-thiazolyl)thieno[3,2-d]pyrimidine-2-amine
4-(thiazol-2-yl)thieno[3,2-d]pyrimidin-2-amine
443148-62-7
CHEMBL259111
SCHEMBL3684455
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C9H6N4S2
|
||||||||||||||||||
| Molecular Weight |
234.309
|
||||||||||||||||||
| Canonical SMILES |
Nc1nc(-c2nccs2)c2sccc2n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C9H6N4S2/c10-9-12-5-1-3-14-7(5)6(13-9)8-11-2-4-15-8/h1-4H,(H2,10,12,13)
Show/Hide
|
||||||||||||||||||
| InChIKey |
CLNBBLGSLDNSMF-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound